N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis

Journal of Gastroenterology

Volumn 51, Issue 4, 2016, Pages 357-369

  Shinzaki, Shinichiro ^a   Ishii, Mayuko ^a   Fujii, Hironobu ^a   Iijima, Hideki ^a   Wakamatsu, Kana ^a   Kawai, Shoichiro ^a   Shiraishi, Eri ^a   Hiyama, Satoshi ^a   Inoue, Takahiro ^a   Hayashi, Yoshito ^a   Kuwahara, Ryusuke ^b   Takamatsu, Shinji ^a   Kamada, Yoshihiro ^a   Morii, Eiichi ^a   Tsujii, Masahiko ^a   Takehara, Tetsuo ^a   Miyoshi, Eiji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Colitic cancer; Macrophage; N Acetylglucosaminyltransferase V; Phagocytosis; Tumorigenesis

Indexed keywords

CLODRONIC ACID; DEXTRAN SULFATE; INTERLEUKIN 10; LATEX; LECTIN; LIPOSOME; N ACETYLGLUCOSAMINYLTRANSFERASE; PHYTOHEMAGGLUTININ; TRINITROBENZENESULFONIC ACID; ALPHA-1,6-MANNOSYLGLYCOPROTEIN BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOTTING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENTERITIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; FLOW CYTOMETRY; MACROPHAGE; MESENTERY LYMPH NODE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SUPERNATANT; WILD TYPE; ANIMAL; C57BL MOUSE; COLITIS; COLON TUMOR; DISEASE MODEL; GENETICS; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TRANSGENIC MOUSE;

ANIMALS; CLODRONIC ACID; COLITIS; COLONIC NEOPLASMS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-10; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; N-ACETYLGLUCOSAMINYLTRANSFERASES; SEVERITY OF ILLNESS INDEX; TRINITROBENZENESULFONIC ACID;

EID: 84940987128     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1119-3     Document Type: Article

References (41)

1. Hart GW, Copeland RJ. Glycomics hits the big time. Cell. 2010;143:672–6.
2. Keusch J, Lydyard PM, Delves PJ. The effect on IgG glycosylation of altering β1,4-galactosyltransferase-1 activity in B cells. Glycobiology. 1998;8:1215–20.
3. Zhao Y, Sato Y, Isaji T, et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 2008;275:1939–48.
4. Taniguchi N, Miyoshi E, Ko JH, et al. Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta. 1999;1455:287–300.
5. Taniguchi N, Ihara S, Saito T, et al. Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor. Glycoconj J. 2001;18:859–65.
6. Granovsky M, Fata J, Pawling J, et al. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med. 2000;6:306–12.
7. Li D, Li Y, Wu X, et al. Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages. J Immunol. 2008;180:3158–65.
8. Miyoshi E, Nishikawa A, Ihara Y, et al. N-Acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res. 1993;53:3899–902.
9. Miyoshi E, Ihara Y, Nishikawa A, et al. Gene expression of N-acetylglucosaminyltransferases III and V: a possible implication for liver regeneration. Hepatology. 1995;22:1847–55.
10. Kimura A, Terao M, Kato A, et al. Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia. Exp Dermatol. 2012;21:515–9.
11. Terao M, Ishikawa A, Nakahara S, et al. Enhanced epithelial-mesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing. J Biol Chem. 2011;286:28303–11.
12. Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol. 2013;48:315–21.
13. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7–17.
14. Shinzaki S, Iijima H, Nakagawa T, et al. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am J Gastroenterol. 2008;103:1173–81.
15. Shinzaki S, Iijima H, Fujii H, et al. Altered oligosaccharide structures reduce colitis induction in mice defective in β-1,4-galactosyltransferase. Gastroenterology. 2012;142:1172–82.
16. Theodoratou E, Campbell H, Ventham NT, et al. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol. 2014;11:588–600.
17. Iijima H, Neurath MF, Nagaishi T, et al. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med. 2004;199:471–82.
18. Dohi T, Ejima C, Kato R, et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology. 2005;128:411–23.
19. Long E, Huynh HT, Zhao X. Involvement of insulin-like growth factor-1 and its binding proteins in proliferation and differentiation of murine bone marrow-derived macrophage precursors. Endocrine. 1998;9:185–92.
20. Aicher WK, Fujihashi K, Yamamoto M, et al. Effects of the lpr/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site. Int Immunol. 1992;4:959–68.
21. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res. 1990;49:186–96.
22. Weisser SB, Brugger HK, Voglmaier NS, et al. SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis. J Leukoc Biol. 2011;90:483–92.
23. Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 1994;107:1643–52.
24. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541–6.
25. Inoue T, Murano M, Abe Y, et al. Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis. J Gastroenterol Hepatol. 2007;22:1474–81.
26. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263–74.
27. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23–35.
28. Edwards JP, Zhang X, Frauwirth KA, et al. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 2006;80:1298–307.
29. Boonstra A, Rajsbaum R, Holman M, et al. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol. 2006;177:7551–8.
30. Murai M, Turovskaya O, Kim G, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. 2009;10:1178–84.
31. Lacy-Hulbert A, Smith AM, Tissire H, et al. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc Natl Acad Sci U S A. 2007;104:15823–8.
32. Chung EY, Liu J, Homma Y, et al. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity. 2007;27:952–64.
33. Kamada N, Hisamatsu T, Okamoto S, et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol. 2005;175:6900–8.
34. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003;3:169–76.
35. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.
36. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–41.
37. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.
38. Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010;107:11942–7.
39. Means TK. Fungal pathogen recognition by scavenger receptors in nematodes and mammals. Virulence. 2010;1:37–41.
40. 88 of Toll-like receptor 4 highlights the critical role of MD-2 in cell surface receptor expression. Int Immunol. 2009;21:925–34.
41. Fiala M, Liu PT, Espinosa-Jeffrey A, et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer’s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A. 2007;104:12849–54.